Table 5.
Relationship between CD20+ lymphocytes and CT improvements.
| CD20+ Lymphocytes (counts/0.1 mm2) | CT improvements § | p value | ||
|---|---|---|---|---|
| CT-Group 1 (n = 17) | CT-Group 2 (n = 19) | CT-Group 3 (n = 14) | ||
| Follicular region | 129.67 (69.08–247.42) | 231.00 (81.83–391.17) | 312.00 (132.96–482.96) | 0.085 |
| Perivascular region | 11.00 (6.58–22.33) | 12.50 (5.50–18.50) | 41.00 (4.71–47.24) | 0.284 |
| Interstitial region | 7.17 (3.83–13.50) | 7.17 (1.50–13.67) | 9.25 (4.92–18.73) | 0.527 |
| Peribronchiolar region | 6.67 (3.33–10.33) | 7.50 (1.17–12.33) | 6.50 (3.38–8.96) | 0.982 |
§Treatment response according to CT findings after 1 year of steroid therapy. Group 1, CT exhibited >30% improvement in ground-glass opacities and reticular opacities; Group 2, CT exhibited <30% improvement; Group 3, CT exhibited no improvement or worsened findings.